EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro
Authors:
- Stephanie DavidSDStephanie David
- Nolwenn LautramNLNolwenn Lautram
- Gaëtan J.-R. DelcroixGDGaëtan J.-R. Delcroix
- Anne ClavreulACAnne Clavreul
- Jean-Pierre BenoitJBJean-Pierre Benoit
- Catherine PassiraniCPCatherine Passirani
- 1 October 2013
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 454 (2) , 748-755
Abstract
No abstract availableKeywords
Funding Information
- Association de recherche contre le cancer
- La ligue contre le cancer
- Structure Fédérative de Recherche – Interactions cellulaires et applications thérapeutiques
This publication has 27 references indexed in Scilit:
- Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expressionCancer Letters, 2013
- Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma TherapyPLOS ONE, 2012
- Brain Distribution of Cediranib Is Limited by Active Efflux at the Blood-Brain BarrierThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Cholesterol-Dependent Macropinocytosis and Endosomal Escape Control the Transfection Efficiency of Lipoplexes in CHO Living CellsMolecular Pharmaceutics, 2012
- Tumor transfection after systemic injection of DNA lipid nanocapsulesBiomaterials, 2011
- The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailabilityBiomaterials, 2010
- Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer TherapyMolecular Therapy, 2010
- Long-circulating DNA lipid nanocapsules as new vector for passive tumor targetingBiomaterials, 2010
- Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenograftsInternational Journal of Cancer, 2008